Niagen Bioscience, Inc. — Director's Dealing 2016

Sep 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2016-09-01

Reporting Person: Jaksch Frank L Jr (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-01	Common Stock	P	1500	$3.32	Acquired	199557	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2075052	Indirect

Footnotes

F1: The Reporting Person no longer has a reportable beneficial interest in 476,334 shares of the Issuer's common stock owned by FMJ Family Limited Relationship and included in the Reporting Person's prior ownership reports.